Literature DB >> 23719712

A novel pilot study of endometrial stromal cells and immune cell populations in sentinel uterine-draining lymph nodes during the menstrual cycle and in endometriosis.

Marina Berbic1, Cecilia H M Ng, Kirsten Black, Robert Markham, Peter Russell, Anthony Basten, Ian S Fraser, Alison J Hey-Cunningham.   

Abstract

Recent studies suggest that changes in certain uterine immune cell populations in endometrium of women with endometriosis are likely to precede changes at ectopic sites. This preliminary study is a first look into the function of uterine-draining lymph nodes (LNs) during the menstrual cycle and in the presence of endometriosis. Paraffin-embedded obturator LNs were obtained from women with (n = 7, mean age 44.3) and without (n = 9, mean age 38.4) endometriosis, who had undergone hysterectomy for cervical or ovarian cancer and in whom LN involvement was not detected. Immunohistochemical staining for endometrial stromal cells and a range of immune cell populations was performed. The CD10+ endometrial stromal cells were detected in uterine-draining LNs throughout the menstrual cycle with numbers peaking during menstruation. The inflammatory process of menstruation was also associated with increased numbers of CD3+, CD4+, Foxp3+, DC-Sign+, CD68+, CD20+, CD79+, and plasma cells. In endometriosis, CD10+ endometrial stromal cells were further increased in numbers, but CD3+, CD4+, DC-Lamp+, FoxP3+, and plasma cells were reduced. This study indicates that efficient immunological responses may be required to contain shed endometrial fragments within the draining uterine LNs thus preventing their further dissemination with establishment of ectopic lesions at distant sites.

Entities:  

Keywords:  endometriosis; immunology; lymph nodes; lymphatic spread; menstrual cycle

Mesh:

Substances:

Year:  2013        PMID: 23719712     DOI: 10.1177/1933719113485298

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  7 in total

Review 1.  The endometrial immune environment of women with endometriosis.

Authors:  Júlia Vallvé-Juanico; Sahar Houshdaran; Linda C Giudice
Journal:  Hum Reprod Update       Date:  2019-09-11       Impact factor: 15.610

2.  Endometrial stromal cells and immune cell populations within lymph nodes in a nonhuman primate model of endometriosis.

Authors:  A J Hey-Cunningham; A T Fazleabas; A G Braundmeier; R Markham; I S Fraser; M Berbic
Journal:  Reprod Sci       Date:  2011-05-26       Impact factor: 3.060

3.  Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility.

Authors:  Kenzie Birse; Kelly B Arnold; Richard M Novak; Stuart McCorrister; Souradet Shaw; Garrett R Westmacott; Terry B Ball; Douglas A Lauffenburger; Adam Burgener
Journal:  J Virol       Date:  2015-06-17       Impact factor: 5.103

4.  Extracellular vesicle-associated VEGF-C promotes lymphangiogenesis and immune cells infiltration in endometriosis.

Authors:  Wan-Ning Li; Kuei-Yang Hsiao; Chu-An Wang; Ning Chang; Pei-Ling Hsu; Chung-Hsien Sun; Shang-Rung Wu; Meng-Hsing Wu; Shaw-Jenq Tsai
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-01       Impact factor: 11.205

5.  Osteopontin Regulates Endometrial Stromal Cell Migration in Endometriosis through the PI3K Pathway : Osteopontin Regulates Endometrial Cell Migration in Endometriosis.

Authors:  Xiaoxia Fu; Mengyun Yao; Chaoshuang Ye; Tao Fang; Ruijin Wu
Journal:  Reprod Sci       Date:  2020-09-09       Impact factor: 3.060

Review 6.  Endometriosis: A Disease with Few Direct Treatment Options.

Authors:  Patricia Ribeiro de Carvalho França; Anna Carolina Pereira Lontra; Patricia Dias Fernandes
Journal:  Molecules       Date:  2022-06-23       Impact factor: 4.927

7.  Toll-Like Receptor Responsiveness of Peripheral Blood Mononuclear Cells in Young Women with Dysmenorrhea.

Authors:  Susan F Evans; Yuen H Kwok; Ann Solterbeck; Jiajun Liu; Mark R Hutchinson; M Louise Hull; Paul E Rolan
Journal:  J Pain Res       Date:  2020-03-09       Impact factor: 3.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.